Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
ABVC BioPharma, Inc. (ABVC) had Cash Flow from Financial Activities of $2.36M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.26M |
|
-- |
|
-- |
|
$2.29M |
|
$-2.29M |
|
$-0.01M |
|
$-2.31M |
|
$-2.28M |
|
$-2.33M |
|
$-2.33M |
|
$-2.33M |
|
$-2.31M |
|
$-2.29M |
|
$-2.21M |
|
17.39M |
|
17.39M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$2.77M |
|
$8.22M |
|
$13.47M |
|
$16.24M |
|
$6.53M |
|
-- |
|
$0.22M |
|
$6.75M |
|
$9.49M |
|
$9.49M |
|
$9.49M |
|
19.53M |
|
| Cash Flow Statement Financials | |
$-1.43M |
|
$-0.67M |
|
|
Cash Flow from Financial Activities |
$2.36M |
$0.86M |
|
$1.08M |
|
$0.21M |
|
$1.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.42 |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.58% |
|
-24.58% |
|
-14.36% |
|
-24.58% |
|
$0.49 |
|
$-0.08 |
|
$-0.08 |
|